Literature DB >> 11408397

Normal blood pressure and renal function in mice lacking the bradykinin B(2) receptor.

A F Milia1, V Gross, R Plehm, J A De Silva, M Bader, F C Luft.   

Abstract

Telemetric blood pressure determinations, heart rate measurements, and pressure-natriuresis-diuresis experiments were used to characterize cardiovascular and renal function in bradykinin B(2) receptor knockout mice fed mouse chow containing 0.25% NaCl or mouse chow containing 4% NaCl. In B(2) receptor knockout mice fed usual mouse chow, the mean arterial blood pressure leveled between 108+/-1 and 110+/-3 mm Hg, and the heart rate leveled between 520+/-26 and 525+/-29 bpm, values that were not different from those measured in B(1) receptor knockout mice or 129Sv/J control mice. Increasing dietary salt intake did not affect mean arterial blood pressure and heart rate. Accordingly, pressure-natriuresis curves, pressure-diuresis curves, renal blood flow, and glomerular filtration rate were not different between B(2) receptor knockout and 129Sv/J mice. Increasing dietary salt intake to 4% increased renal blood flow to levels between 8.41 and 9.50 mL/min per gram kidney wet weight in 129Sv/J mice, whereas in B(2) receptor-deficient mice, renal blood flow was not affected and ranged between 6.85 and 7.88 mL/min per gram kidney wet weight. Other renal function parameters were not affected. Absence of B(2) receptor function was verified in B(2) receptor knockout mice with bradykinin infusion. These data suggest that the absence of B(2) receptor function does not necessarily make B(2) receptor knockout mice hypertensive or induce salt sensitivity. Presumably, differences in the genetic background or an adaptation to the loss of B(2) receptor function may account for these results, in contrast with earlier reports involving B(2) receptor knockout mice. We hold the latter possibility to be more likely and to be a fruitful possibility for future research.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11408397     DOI: 10.1161/01.hyp.37.6.1473

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  13 in total

Review 1.  Mechanisms of pressure natriuresis.

Authors:  Joey P Granger; Barbara T Alexander; Mayte Llinas
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

Review 2.  Update on angiotensin AT2 receptors.

Authors:  Robert M Carey
Journal:  Curr Opin Nephrol Hypertens       Date:  2017-03       Impact factor: 2.894

3.  Bradykinin Stimulates Renal Na+ and K+ Excretion by Inhibiting the K+ Channel (Kir4.1) in the Distal Convoluted Tubule.

Authors:  Dan-Dan Zhang; Zhong-Xiuzi Gao; Carlos P Vio; Yu Xiao; Peng Wu; Hao Zhang; Xi-Wen Guo; Xin-Xin Meng; Li Gu; Jun-Lin Wang; Xin-Peng Duan; Dao-Hong Lin; Wen-Hui Wang; Ruimin Gu
Journal:  Hypertension       Date:  2018-06-18       Impact factor: 10.190

4.  Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor.

Authors:  Masao Kakoki; Nobuyuki Takahashi; J Charles Jennette; Oliver Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

Review 5.  The kallikrein-kinin system as a regulator of cardiovascular and renal function.

Authors:  Nour-Eddine Rhaleb; Xiao-Ping Yang; Oscar A Carretero
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

6.  Reproducibility of Contrast-Enhanced Ultrasound in Mice with Controlled Injection.

Authors:  Alexandre Dizeux; Thomas Payen; Guillaume Barrois; Delphine Le Guillou Buffello; S Lori Bridal
Journal:  Mol Imaging Biol       Date:  2016-10       Impact factor: 3.488

Review 7.  The kallikrein-kinin system in health and in diseases of the kidney.

Authors:  Masao Kakoki; Oliver Smithies
Journal:  Kidney Int       Date:  2009-02-04       Impact factor: 10.612

8.  Role of Mas Receptor Antagonist A799 in Renal Blood Flow Response to Ang 1-7 after Bradykinin Administration in Ovariectomized Estradiol-Treated Rats.

Authors:  Aghdas Dehghani; Shadan Saberi; Mehdi Nematbakhsh
Journal:  Adv Pharmacol Sci       Date:  2015-09-03

Review 9.  A Novel Category of Anti-Hypertensive Drugs for Treating Salt-Sensitive Hypertension on the Basis of a New Development Concept.

Authors:  Makoto Katori; Masataka Majima
Journal:  Pharmaceuticals (Basel)       Date:  2010-01-07

10.  How Does Circadian Rhythm Impact Salt Sensitivity of Blood Pressure in Mice? A Study in Two Close C57Bl/6 Substrains.

Authors:  Roy Combe; John Mudgett; Lahcen El Fertak; Marie-France Champy; Estelle Ayme-Dietrich; Benoit Petit-Demoulière; Tania Sorg; Yann Herault; Jeffrey B Madwed; Laurent Monassier
Journal:  PLoS One       Date:  2016-04-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.